BCLI logo

BCLI Operating Expenses

Annual Operating Expenses

$21.44 M
-$3.38 M-13.63%

December 31, 2023


Summary


Performance

BCLI Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBCLIexpensesmetrics:

Quarterly Operating Expenses

$3.05 M
+$66.00 K+2.21%

September 30, 2024


Summary


Performance

BCLI Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBCLIexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

BCLI Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.6%+2.2%
3 y3 years-32.3%+2.2%
5 y5 years+52.5%+2.2%

BCLI Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-13.6%at low-59.9%+23.2%
5 y5-year-32.3%at low-73.5%+23.2%
alltimeall time-32.3%>+9999.0%-81.6%+1380.7%

Brainstorm Cell Therapeutics Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$3.05 M(+2.2%)
Jun 2024
-
$2.98 M(+20.5%)
Mar 2024
-
$2.47 M(-48.5%)
Dec 2023
$21.44 M(-13.6%)
$4.80 M(-20.4%)
Sep 2023
-
$6.04 M(+10.8%)
Jun 2023
-
$5.45 M(+5.8%)
Mar 2023
-
$5.15 M(+4.8%)
Dec 2022
$24.82 M(+1.2%)
$4.92 M(-28.2%)
Sep 2022
-
$6.84 M(-9.9%)
Jun 2022
-
$7.59 M(+38.6%)
Mar 2022
-
$5.47 M(-11.9%)
Dec 2021
$24.54 M(-22.6%)
$6.21 M(+17.7%)
Sep 2021
-
$5.28 M(-13.8%)
Jun 2021
-
$6.12 M(-11.7%)
Mar 2021
-
$6.93 M(-39.7%)
Dec 2020
$31.68 M(+37.8%)
$11.49 M(+156.2%)
Sep 2020
-
$4.49 M(-39.4%)
Jun 2020
-
$7.40 M(-10.9%)
Mar 2020
-
$8.31 M(+8.4%)
Dec 2019
$23.00 M(+63.6%)
$7.67 M(+38.1%)
Sep 2019
-
$5.55 M(+14.3%)
Jun 2019
-
$4.86 M(-1.4%)
Mar 2019
-
$4.93 M(-9.4%)
Dec 2018
$14.06 M(+181.3%)
$5.44 M(+68.2%)
Sep 2018
-
$3.23 M(+4.7%)
Jun 2018
-
$3.09 M(+33.8%)
Mar 2018
-
$2.31 M(-1069.3%)
Dec 2017
$5.00 M(-1.7%)
-$238.00 K(-109.9%)
Sep 2017
-
$2.39 M(+122.5%)
Jun 2017
-
$1.07 M(-39.3%)
Mar 2017
-
$1.77 M(+172.3%)
Dec 2016
$5.08 M(-40.5%)
$650.00 K(-60.3%)
Sep 2016
-
$1.64 M(+66.6%)
Jun 2016
-
$983.00 K(-45.8%)
Mar 2016
-
$1.81 M(+29.7%)
Dec 2015
$8.54 M(+15.0%)
$1.40 M(-45.7%)
Sep 2015
-
$2.57 M(+8.8%)
Jun 2015
-
$2.36 M(+7.2%)
Mar 2015
-
$2.21 M(-17.3%)
Dec 2014
$7.42 M(+47.2%)
$2.67 M(+9.7%)
Sep 2014
-
$2.43 M(+87.8%)
Jun 2014
-
$1.29 M(+25.5%)
Mar 2014
-
$1.03 M(-26.4%)
Dec 2013
$5.04 M
$1.40 M(+30.2%)
Sep 2013
-
$1.08 M(-27.5%)
DateAnnualQuarterly
Jun 2013
-
$1.49 M(+37.4%)
Mar 2013
-
$1.08 M(+70.2%)
Dec 2012
$3.52 M(-9.7%)
$635.00 K(-45.8%)
Sep 2012
-
$1.17 M(+40.7%)
Jun 2012
-
$833.00 K(-5.2%)
Mar 2012
-
$879.00 K(-37.3%)
Dec 2011
$3.89 M(+50.4%)
$1.40 M(+89.6%)
Sep 2011
-
$740.00 K(-47.7%)
Jun 2011
-
$1.42 M(+168.0%)
Mar 2011
-
$528.00 K(-27.6%)
Dec 2010
$2.59 M(+47.9%)
$729.00 K(+14.8%)
Sep 2010
-
$635.00 K(+3.1%)
Jun 2010
-
$616.00 K(+1.1%)
Mar 2010
-
$609.00 K(+554.8%)
Dec 2009
$1.75 M(-46.5%)
$93.00 K(-84.3%)
Sep 2009
-
$593.00 K(+13.2%)
Jun 2009
-
$524.00 K(-3.0%)
Mar 2009
-
$540.00 K(-20.0%)
Dec 2008
$3.27 M(-33.5%)
$675.00 K(-3.2%)
Sep 2008
-
$697.00 K(-8.5%)
Jun 2008
-
$762.00 K(-32.8%)
Mar 2008
-
$1.13 M(+91.2%)
Dec 2007
$4.92 M(+70.5%)
$593.00 K(-59.3%)
Sep 2007
-
$1.46 M(+68.8%)
Jun 2007
-
$863.00 K(-35.5%)
Mar 2007
-
$1.34 M(+50.4%)
Dec 2006
$2.88 M(-12.7%)
-
Sep 2006
-
$890.00 K(+6.9%)
Jun 2006
-
$832.40 K(+33.3%)
Mar 2006
-
$624.30 K(-31.8%)
Mar 2006
$3.30 M(-82.5%)
-
Dec 2005
-
$915.00 K(-11.1%)
Sep 2005
-
$1.03 M(+40.4%)
Jun 2005
-
$732.80 K(+13.2%)
Mar 2005
$18.83 M(>+9900.0%)
$647.60 K(-96.1%)
Dec 2004
-
$16.60 M(+954.4%)
Sep 2004
-
$1.57 M(>+9900.0%)
Dec 2003
-
$14.60 K(+32.7%)
Sep 2003
-
$11.00 K(-7.6%)
Jun 2003
-
$11.90 K(+357.7%)
Mar 2003
$58.00 K(+51.4%)
$2600.00(-90.8%)
Dec 2002
-
$28.30 K(+78.0%)
Sep 2002
-
$15.90 K(+42.0%)
Jun 2002
-
$11.20 K
Mar 2002
$38.30 K
-

FAQ

  • What is Brainstorm Cell Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Brainstorm Cell Therapeutics?
  • What is Brainstorm Cell Therapeutics annual operating expenses year-on-year change?
  • What is Brainstorm Cell Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Brainstorm Cell Therapeutics?
  • What is Brainstorm Cell Therapeutics quarterly operating expenses year-on-year change?

What is Brainstorm Cell Therapeutics annual total operating expenses?

The current annual operating expenses of BCLI is $21.44 M

What is the all time high annual operating expenses for Brainstorm Cell Therapeutics?

Brainstorm Cell Therapeutics all-time high annual total operating expenses is $31.68 M

What is Brainstorm Cell Therapeutics annual operating expenses year-on-year change?

Over the past year, BCLI annual total operating expenses has changed by -$3.38 M (-13.63%)

What is Brainstorm Cell Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of BCLI is $3.05 M

What is the all time high quarterly operating expenses for Brainstorm Cell Therapeutics?

Brainstorm Cell Therapeutics all-time high quarterly total operating expenses is $16.60 M

What is Brainstorm Cell Therapeutics quarterly operating expenses year-on-year change?

Over the past year, BCLI quarterly total operating expenses has changed by +$66.00 K (+2.21%)